115 related articles for article (PubMed ID: 38358185)
21. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients.
Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H
Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849
[TBL] [Abstract][Full Text] [Related]
22. High expression of P2X7R is an independent postoperative indicator of poor prognosis in colorectal cancer.
Qian F; Xiao J; Hu B; Sun N; Yin W; Zhu J
Hum Pathol; 2017 Jun; 64():61-68. PubMed ID: 28412208
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of PLAC1 and Netrin-1 in liver metastasis of colorectal cancer and its predictive value.
Wang Z; Deng L; Xu X; Zhao L
BMC Gastroenterol; 2023 Aug; 23(1):275. PubMed ID: 37568074
[TBL] [Abstract][Full Text] [Related]
25. Expression of ZNF148 in different developing stages of colorectal cancer and its prognostic value: a large Chinese study based on tissue microarray.
Gao XH; Liu QZ; Chang W; Xu XD; Du Y; Han Y; Liu Y; Yu ZQ; Zuo ZG; Xing JJ; Cao G; Fu CG
Cancer; 2013 Jun; 119(12):2212-22. PubMed ID: 23576061
[TBL] [Abstract][Full Text] [Related]
26. Gab2 is a novel prognostic factor for colorectal cancer patients.
Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
[TBL] [Abstract][Full Text] [Related]
27. MTSS1 overexpression correlates with poor prognosis in colorectal cancer.
Wang D; Xu MR; Wang T; Li T; Zhu Jw
J Gastrointest Surg; 2011 Jul; 15(7):1205-12. PubMed ID: 21562916
[TBL] [Abstract][Full Text] [Related]
28. Comparison of non-schistosomal colorectal cancer and schistosomal colorectal cancer.
Wang W; Lu K; Wang L; Jing H; Pan W; Huang S; Xu Y; Bu D; Cheng M; Liu J; Liu J; Shen W; Zhang Y; Yao J; Zhu T
World J Surg Oncol; 2020 Jul; 18(1):149. PubMed ID: 32611359
[TBL] [Abstract][Full Text] [Related]
29. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
[TBL] [Abstract][Full Text] [Related]
30. [Expression of NF-E1b in colorectal cancer tissues and its clinical significance].
Xu K; Chen L; Di J; Wang Z; Wang A; Wu W; Wu F; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):685-9. PubMed ID: 27353105
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylated p38, a negative prognostic biomarker, complements TNM staging prognostication in colorectal cancer.
Fan XJ; Wan XB; Fu XH; Wu PH; Chen DK; Wang PN; Jiang L; Wang DH; Chen ZT; Huang Y; Wang JP; Wang L
Tumour Biol; 2014 Oct; 35(10):10487-95. PubMed ID: 25056534
[TBL] [Abstract][Full Text] [Related]
32. The high expression of FOXE1 in colorectal cancer predicts a promising prognosis: a retrospective study.
Liu X; Chen L; Wen F; Zheng S; Ge W
Clin Exp Med; 2023 Nov; 23(7):3995-4001. PubMed ID: 37278933
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of CPE-ΔN predicts poor prognosis in colorectal cancer patients.
Zhou K; Liang H; Liu Y; Yang C; Liu P; Jiang X
Tumour Biol; 2013 Dec; 34(6):3691-9. PubMed ID: 23852859
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of miR-552 acts as a potential predictor biomarker for poor prognosis of colorectal cancer.
Wang N; Liu W
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):412-416. PubMed ID: 29424898
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA HANR as a biomarker for the diagnosis and prognosis of colorectal cancer.
Xu M; Guo X; Wang RD; Zhang ZH; Jia YM; Sun X
Medicine (Baltimore); 2020 Feb; 99(7):e19066. PubMed ID: 32049807
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic value of syndecan binding protein in colorectal carcinoma].
Liu H; Yang L; Ding Y; Zhao Z; Yu Q
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jul; 35(7):1003-7. PubMed ID: 26198950
[TBL] [Abstract][Full Text] [Related]
37. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.
Yu D; Li Z; Gan M; Zhang H; Yin X; Tang S; Wan L; Tian Y; Zhang S; Zhu Y; Lai M; Zhang D
Tumour Biol; 2015 Nov; 36(11):8531-5. PubMed ID: 26032091
[TBL] [Abstract][Full Text] [Related]
38. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
[TBL] [Abstract][Full Text] [Related]
39. Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer.
Ma J; Zhang S; Hu Y; Li X; Yuan F; Sun D; Wang L; Zhang F; Chen G; Cui P
Medicine (Baltimore); 2017 Oct; 96(42):e7011. PubMed ID: 29049167
[TBL] [Abstract][Full Text] [Related]
40. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
